| Solara Active Pharma Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541540 |
NSE Symbol : SOLARA |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE624Z01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 345.20 |
Market Cap(₹Cr) : 2,096.03 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 387.29 | 349.00 | 313.54 | 319.15 | 273.01 | 300.31 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 387.29 | 349.00 | 313.54 | 319.15 | 273.01 | 300.31 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.28 | 0.00 | 0.49 | 0.98 | 5.95 | 1.49 |
| Total Income | 392.57 | 349.00 | 314.03 | 320.13 | 278.96 | 301.80 |
| Total Expenditure | 329.74 | 318.40 | 278.79 | 262.12 | 230.42 | 242.62 |
| PBIDT | 62.83 | 30.60 | 35.24 | 58.01 | 48.54 | 59.18 |
| Interest | 27.06 | 22.45 | 20.83 | 23.90 | 29.12 | 26.54 |
| PBDT | 35.77 | 8.15 | 14.41 | 34.11 | 19.42 | 32.64 |
| Depreciation | 26.04 | 25.57 | 24.49 | 23.58 | 24.30 | 24.54 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 9.73 | -17.42 | -10.08 | 10.53 | -4.88 | 8.10 |
| Extra-ordinary Items | 0.86 | -6.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.87 | -10.67 | -10.08 | 10.53 | -4.88 | 8.10 |
| EPS (Unit Curr.) | 2.23 | -3.97 | -2.36 | 2.46 | -1.65 | 2.47 |
| EPS (Adj) (Unit Curr.) | 2.23 | -3.97 | -2.36 | 2.46 | -1.65 | 2.47 |
| Calculated EPS (Unit Curr.) | 2.19 | -3.92 | -2.27 | 2.37 | -1.21 | 2.01 |
| Calculated EPS (Adj) (Unit Curr.) | 2.19 | -3.92 | -2.27 | 2.37 | -1.21 | 2.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.74 | -15.66 | -9.07 | 9.50 | -4.85 | 8.05 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.74 | -15.66 | -9.07 | 9.50 | -4.85 | 8.05 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 44.51 | 44.49 | 44.47 | 44.34 | 40.25 | 40.25 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.22 | 8.77 | 11.24 | 18.18 | 17.78 | 19.71 |
| PBDTM(%) | 9.24 | 2.34 | 4.60 | 10.69 | 7.11 | 10.87 |
| PATM(%) | 2.51 | -4.99 | -3.21 | 3.30 | -1.79 | 2.70 |
